인바이오

352940KOSDAQ비료, 농약 및 살균, 살충제 제조업

47.8 / 100

Reference Date: 2026-06-10

Financial Score12.5 / 40

News Sentiment21.3 / 25

Momentum4.0 / 20

Disclosure10.0 / 15

AI Analysis: PBR is undervalued vs. peers but ROE is below the industry average. Declined 13.9% over the past month, and news sentiment is neutral.

Company InformationBased on 2025 Annual Report

Business Overview

Inbio produces and sells multifunctional pesticides, herbicides, and eco-friendly crop protection products, developing combined formulations to reduce farmers' workload and increase agricultural income. Responding to rising demand for labor-saving combined products, the company invests in R&D to differentiate its offerings through enhanced efficacy and user convenience, driving market growth.

Number of Employees

158people

Average Salary

44.2M KRW

Score Calculation Basis

Detailed Financial Score

PER

21.67Industry Average 12.891.5Point

1.7x industry avg (risky)

PBR

0.52Industry Average 0.584.0Point

In line with industry avg

ROE

2.41Industry Average 4.322.5Point

Below industry avg

Debt Ratio

12.23Industry Average 7.870.5Point

1.6x industry avg (risky)

Trend 2023~20254.0 / 10 points

Revenue Growth Rate

1.0 / 3

Avg ▲0.0% (2-year basis)

Operating Profit Growth Rate

3.0 / 3

Avg ▲53.6% (2-year basis)

ROE Trend

0.0 / 4

Avg ROE -3.5% (improving, 3yr)

Detailed News Sentiment

1 totalPositive 1Neutral 0Negative 0Average Sentiment Score 85

Positive
인바이오, 살균제 신물질 관련 NDA 체결
인바이오가 글로벌 작물보호 기업과의 NDA 체결로 신물질 기술 협력이 시작되어 성장 기대감이 높아짐.

Detailed Momentum

52-week position1.0Point

Near 52w low (3%, downtrend)

Current 2,015Won52-week high 2,79552-week low 1,984

1-month return1.0Point

1m -13.89% (falling)

Volume trend2.0Point

Volume decreasing

Detailed Disclosure

4 totalPositive 0Neutral 4Negative 0

Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-06-05
Neutral주주총회소집공고2026-06-02
Neutral[기재정정]주주총회소집결의 (임시주주총회)2026-06-01
Neutral분기보고서 (2026.03)2026-05-14